Three of these cases also exhibited concurrent alterations in the tumour suppressor genes ARID1A, NF1, or RB1, suggesting even poorer prognosis and a need for more intensive follow‐up or more aggressive interventions beyond EGFR TKI monotherapy [18]. The gene discussed is NF1; the disease is neoplasm.